Hazell A S, Norenberg M D
Laboratory of Neuropathology, Veterans Administration Medical Center, Miami, Florida 33125, USA.
Neurochem Res. 1997 Dec;22(12):1443-7. doi: 10.1023/a:1021994126329.
Recent data have shown an accumulation of manganese in the basal ganglia in patients with chronic hepatic encephalopathy (HE). Astrocytes and ammonia are critically involved in the pathogenesis of HE, and we have recently demonstrated that ammonia decreases glutamate uptake in cultured astrocytes. Since failure by astrocytes to take up glutamate may represent an important pathogenetic mechanism in HE, we, therefore, examined the effect of manganese on glutamate transport in these cells. Treatment of cultured astrocytes with 100 microM manganese for 2 days resulted in a 54% decrease in the uptake of D-aspartate, a nonmetabolizable analogue of glutamate. Kinetic analysis revealed a 28% decline in Vmax, with no change in the K(m). Treatment of cultures with 5 mM NH4 Cl inhibited D-aspartate uptake by 21%, and a combination of 5 mM NH4Cl with 100 microM manganese produced an additive effect on uptake inhibition. These results suggest a pathogenetic role for manganese in HE, possibly involving glutamate transport.
近期数据显示,慢性肝性脑病(HE)患者基底神经节中有锰蓄积。星形胶质细胞和氨在HE的发病机制中起关键作用,并且我们最近证明氨会降低培养的星形胶质细胞对谷氨酸的摄取。由于星形胶质细胞摄取谷氨酸失败可能是HE的一种重要发病机制,因此,我们研究了锰对这些细胞中谷氨酸转运的影响。用100微摩尔/升锰处理培养的星形胶质细胞2天,导致D-天冬氨酸(一种不可代谢的谷氨酸类似物)摄取减少54%。动力学分析显示最大摄取速率(Vmax)下降28%,而米氏常数(K(m))无变化。用5毫摩尔/升氯化铵处理培养物可使D-天冬氨酸摄取抑制21%,5毫摩尔/升氯化铵与100微摩尔/升锰联合使用对摄取抑制产生相加作用。这些结果表明锰在HE中具有发病机制作用,可能涉及谷氨酸转运。